{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260507366251/en/ImmunityBio-Reports-Record-Q1-2026-Results-Net-Product-Revenue-Increased-Nearly-2.7x-Year-Over-Year-to-44-Million-in-Q1-2026-Expanding-on-the-2025-Full-Year-700-Year-Over-Year-Revenue-Growth-Cash-and-Marketable-Securities-Total-381-Million", "message": "News view counter 709656 successfully enlarged"}